Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Pfizer to deliver 2.5 million additional doses of Covid-19 pill to UK
Pharmaceutical Business Review
Sun, 12/26/21 - 11:12 pm
Pfizer
Paxlovid
COVID-19
UK
FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited
Stat
Thu, 12/23/21 - 12:03 pm
FDA
Merck
molnupiravir
COVID-19
Novavax says COVID vaccine triggers immune response to Omicron variant
Yahoo/Reuters
Wed, 12/22/21 - 11:45 pm
Novavax
COVID-19
vaccines
Omicron COVID-19 variant
2022 forecast: Will biopharma's offices ever go back to 'normal'? Sanofi, Novartis and more chime in
Fierce Pharma
Wed, 12/22/21 - 11:37 pm
COVID-19
pandemic
remote work
Sanofi
Biogen
Pfizer
Novartis
Top regulator says need for Omicron vaccine depends on staying power of variant
Stat
Wed, 12/22/21 - 11:33 pm
vaccines
COVID-19
Omicron COVID-19 variant
COVID-19 pill from Pfizer authorized by FDA in major pandemic milestone
BioPharma Dive
Wed, 12/22/21 - 02:29 pm
Pfizer
Paxlovid
antivirals
COVID-19
FDA
White House to buy, ship 500 million rapid tests for free beginning in January
Stat
Tue, 12/21/21 - 10:26 am
COVID-19
diagnostics
pandemic
Omicron COVID-19 variant
Joe Biden
The power of Next Generation Sequencing in management of the pandemic and future outbreaks
MedCity News
Tue, 12/21/21 - 10:20 am
COVID-19
pandemic
next generation sequencing
Moderna could be ready to develop Omicron booster in weeks - CEO
Yahoo/Reuters
Tue, 12/21/21 - 10:11 am
Moderna Therapeutics
COVID-19
vaccines
Omicron COVID-19 variant
Stephane Bancel
boosters
Omicron variant now makes up 73% of Covid infections diagnosed in U.S.
Stat
Mon, 12/20/21 - 11:41 pm
COVID-19
pandemic
Omicron COVID-19 variant
CDC
Green light for Novavax COVID-19 vaccine in the EU
Biopharma Reporter
Mon, 12/20/21 - 11:27 pm
Novavax
COVID-19
Europe
vaccines
Moderna vaccine weaker against omicron, but third shot boosts protection
BioPharma Dive
Mon, 12/20/21 - 11:25 pm
Moderna Therapeutics
COVID-19
vaccines
boosters
Omicron COVID-19 variant
Mesoblast considers plans for COVID treatment after Novartis exits deal
Biopharma Reporter
Mon, 12/20/21 - 10:48 am
Mesoblast
Novartis
clinical trials
COVID-19
This New Study Could Give Moderna a Big Advantage in 2022
Motley Fool
Sat, 12/18/21 - 10:46 pm
Moderna Therapeutics
Pfizer
AstraZeneca
COVID-19
vaccines
boosters
Preliminary laboratory data hint at what makes Omicron the most superspreading variant yet
Stat
Fri, 12/17/21 - 11:17 am
COVID-19
Public Health
pandemic
Omicron COVID-19 variant
Pfizer plans to study a third shot for its Covid-19 vaccine in the youngest kids, pushing back its timeline farther
Endpoints
Fri, 12/17/21 - 11:04 am
Pfizer
COVID-19
vaccines
pediatric
clinical trials
As Omicron cases rise, EMA backs early use of Pfizer’s Paxlovid
Pharmaforum
Fri, 12/17/21 - 11:00 am
Pfizer
Paxlovid
EMA
Europe
COVID-19
Omicron COVID-19 variant
Citing blood clot risks, CDC advisers recommend mRNA pandemic vaccines over J&J shot
Fierce Pharma
Fri, 12/17/21 - 12:02 am
JNJ
vaccines
COVID-19
blood clots
FDA
MRNA
Pfizer files for full FDA approval of COVID-19 vaccine in adolescents
Yahoo/Reuters
Thu, 12/16/21 - 11:56 pm
Pfizer
BioNTech
COVID-19
FDA
adolescents
Pfizer, Moderna Vaccines Less Effective Against Delta In Elderly And Protection Wanes Rapidly Four Months After Second Covid Shot, Study Finds
Forbes
Thu, 12/16/21 - 11:16 am
Pfizer
Moderna Therapeutics
COVID-19
vaccines
elderly
Pages
« first
‹ previous
…
36
37
38
39
40
41
42
43
44
…
next ›
last »